Delivery Order SPE2DB20D3103-SPE2DB25FP8M9
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $7.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,120.74 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 500 mg vials. The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, operates under firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $44,261.94 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 2 GM vials. This contract, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, operates under a firm fixed-price arrangement with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $26,197.80 on July 22, 2025, for the supply of Cyclophosphamide 2 GM vials, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,580.30 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 1 GM vials, with an ultimate completion date of September 5, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Cyclophosphamide 2 GM/10 ML vials (10 mL quantity) with a ceiling value of $5,245.52. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 500 mg vials under a firm fixed-price contract valued at $1,226.03. This competitively awarded, non-set-aside delivery order was issued on June 30, 2025, with an ultimate completion date of July 1, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Cyclophosphamide is a critical chemotherapy agent used in military and federal healthcare...
- The Defense Logistics Agency awarded a $1,867.90 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Cyclophosphamide 500 mg vials, with an ultimate completion date of September 17, 2025. This firm fixed-price contract represents a non-set-aside award issued through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs and...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency Medical Supply Chain on July 15, 2025, for the supply of Cyclophosphamide 2 GM/10 ML vials (10 mL quantity) with a ceiling value of $2,032.66. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on an open basis. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The...
- The Defense Logistics Agency awarded a $5,270.96 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Cyclophosphamide 1 GM/5 ML in 5 ML vials. This competitive award, utilizing firm fixed price contracting, is scheduled for completion by September 12, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was awarded through full and open competition. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,316.80 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Cyclophosphamide 1 GM/5 ML vials (5 ML quantity). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...